<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04740957</url>
  </required_header>
  <id_info>
    <org_study_id>IRAS 246354</org_study_id>
    <nct_id>NCT04740957</nct_id>
  </id_info>
  <brief_title>Characterising the Natural History of Mucosal Metabolism During Colorectal Anastomotic Healing</brief_title>
  <official_title>Characterising the Natural History of Mucosal Metabolism During Colorectal Anastomotic Healing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot study aims to investigate anastomotic healing and its underlying mechanisms at a&#xD;
      mucosal level. It is a first-in-human study which will demonstrate the safety of&#xD;
      post-operative endoscopic assessment of a colorectal anastomosis and provide preliminary data&#xD;
      in order to power future interventional studies.&#xD;
&#xD;
      100 patients undergoing elective left colonic or rectal resection with a primary anastomosis&#xD;
      will be recruited pre-operatively throughout the study period. This study will not affect or&#xD;
      delay the intended treatment for study participants.&#xD;
&#xD;
      Patients will undergo serial endoscopic examination of the anastomosis post-operatively.&#xD;
      Blood, urine, stool, and mucosal biopsies will be serially collected.&#xD;
&#xD;
      A subgroup of 20 patients with a defunctioning ileostomy will be recruited to an&#xD;
      interventional arm. This interventional arm will demonstrate the safety of re-introducing&#xD;
      ileostomy effluent into the downstream (distal) limb of an ileostomy. The preliminary data&#xD;
      will enable exploration of the association between microbiome and post-operative function and&#xD;
      enable adequate powering of future interventional studies.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">October 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anastomotic healing</measure>
    <time_frame>1 year</time_frame>
    <description>Healing of the colorectal anastomosis as defined by endoscopic appearances and return of bowel function.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Healing of Colorectal Anastomoses</condition>
  <arm_group>
    <arm_group_label>Observational cohort</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>100 patients undergoing elective left colonic or rectal resection with a primary anastomosis will be recruited pre-operatively throughout the study period. This study will not affect or delay the intended treatment for study participants.&#xD;
Patients will undergo serial endoscopic examination of the anastomosis post-operatively. Blood, urine, stool, and mucosal biopsies will be serially collected.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Distal limb feeding cohort</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This interventional arm will demonstrate the safety of re-introducing ileostomy effluent into the downstream (distal) limb of an ileostomy. The preliminary data will enable exploration of the association between microbiome and post-operative function and enable adequate powering of future interventional studies.&#xD;
A subgroup of 20 patients undergoing a resection with a covering ileostomy will be recruited to the intervention arm. Complete healing of the colorectal anastomosis will first be confirmed by water-soluble contrast enema 8 weeks post-operatively (this is standard practice). Patients will be taught how to inject the output from the proximal ileostomy limb into the distal limb (this connects to the colon and thus the colorectal anastomosis) daily until the ileostomy closure date.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Distal limb reintroduction of ileostomy effluent</intervention_name>
    <description>Patients will undergo water soluble contrast enema to confirm anastomotic healing 8 weeks post operatively as per standard practice at Imperial.&#xD;
Patients will be educated in how to reintroduce ileostomy output to the distal (downstream) loop of their ileostomy. They will be asked to reintroduce 50ml of ileostomy output using a conventional long-tipped bladder syringe daily until surgery to close the stoma.</description>
    <arm_group_label>Distal limb feeding cohort</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients undergoing elective left sided colonic or rectal resections with primary&#xD;
        anastomosis with or without diverting ileostomy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to communicate in English&#xD;
&#xD;
          -  People who lack capacity to consent&#xD;
&#xD;
          -  Emergency colorectal resection whilst awaiting elective surgery&#xD;
&#xD;
          -  Age &lt;18&#xD;
&#xD;
          -  Permanent stoma formation&#xD;
&#xD;
          -  People on long term immunosuppressive medication&#xD;
&#xD;
          -  People on long term renal replacement therapy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>James Kinross, PhD FRCS</last_name>
    <phone>020 3312 2124</phone>
    <email>j.kinross@imperial.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>James Lewis, MRCS</last_name>
    <phone>020 3312 2124</phone>
    <email>james.lewis1@imperial.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Imperial College Healthcare NHS Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Kinross, PhD FRCS</last_name>
      <phone>020 3312 2124</phone>
      <email>j.kinross@imperial.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>James Lewis, MBBS</last_name>
      <phone>020 3312 2124</phone>
      <email>james.lewis1@imperial.ac.uk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 3, 2021</study_first_submitted>
  <study_first_submitted_qc>February 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2021</study_first_posted>
  <last_update_submitted>February 3, 2021</last_update_submitted>
  <last_update_submitted_qc>February 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

